189 related articles for article (PubMed ID: 27279060)
21. Folding and misfolding of the prion protein in the secretory pathway.
Tatzelt J; Winklhofer KF
Amyloid; 2004 Sep; 11(3):162-72. PubMed ID: 15523918
[TBL] [Abstract][Full Text] [Related]
22. Human prion disease and human prion protein disease.
Kitamoto T; Tateishi J
Curr Top Microbiol Immunol; 1996; 207():27-34. PubMed ID: 8575204
[No Abstract] [Full Text] [Related]
23. Monoacylated cellular prion protein modifies cell membranes, inhibits cell signaling, and reduces prion formation.
Bate C; Williams A
J Biol Chem; 2011 Mar; 286(11):8752-8. PubMed ID: 21212283
[TBL] [Abstract][Full Text] [Related]
24. Metabolic aspects of prion diseases: an overview.
Vranac T; Bresjanac M
Curr Drug Targets; 2010 Oct; 11(10):1207-17. PubMed ID: 20840065
[TBL] [Abstract][Full Text] [Related]
25. PrPC knockdown by liposome-siRNA-peptide complexes (LSPCs) prolongs survival and normal behavior of prion-infected mice immunotolerant to treatment.
Bender H; Noyes N; Annis JL; Hitpas A; Mollnow L; Croak K; Kane S; Wagner K; Dow S; Zabel M
PLoS One; 2019; 14(7):e0219995. PubMed ID: 31329627
[TBL] [Abstract][Full Text] [Related]
26. Uncontrolled SFK-mediated protein trafficking in prion and Alzheimer's disease.
Málaga-Trillo E; Ochs K
Prion; 2016 Sep; 10(5):352-361. PubMed ID: 27649856
[TBL] [Abstract][Full Text] [Related]
27. GPI-anchor signal sequence influences PrPC sorting, shedding and signalling, and impacts on different pathomechanistic aspects of prion disease in mice.
Puig B; Altmeppen HC; Linsenmeier L; Chakroun K; Wegwitz F; Piontek UK; Tatzelt J; Bate C; Magnus T; Glatzel M
PLoS Pathog; 2019 Jan; 15(1):e1007520. PubMed ID: 30608982
[TBL] [Abstract][Full Text] [Related]
28. The function of the cellular prion protein in health and disease.
Watts JC; Bourkas MEC; Arshad H
Acta Neuropathol; 2018 Feb; 135(2):159-178. PubMed ID: 29151170
[TBL] [Abstract][Full Text] [Related]
29. Therapy for prion diseases: Insights from the use of RNA interference.
White MD; Mallucci GR
Prion; 2009; 3(3):121-8. PubMed ID: 19597349
[TBL] [Abstract][Full Text] [Related]
30. Alzheimer's and prion disease as disorders of protein conformation: implications for the design of novel therapeutic approaches.
Soto C
J Mol Med (Berl); 1999 May; 77(5):412-8. PubMed ID: 10426190
[TBL] [Abstract][Full Text] [Related]
31. Cellular prion protein null mice display normal AMPA receptor mediated long term depression.
Khosravani H; Zhang Y; Zamponi GW
Prion; 2008; 2(2):48-50. PubMed ID: 19098438
[TBL] [Abstract][Full Text] [Related]
32. Molecular cross talk between misfolded proteins in animal models of Alzheimer's and prion diseases.
Morales R; Estrada LD; Diaz-Espinoza R; Morales-Scheihing D; Jara MC; Castilla J; Soto C
J Neurosci; 2010 Mar; 30(13):4528-35. PubMed ID: 20357103
[TBL] [Abstract][Full Text] [Related]
33. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers.
Ugalde CL; Finkelstein DI; Lawson VA; Hill AF
J Neurochem; 2016 Oct; 139(2):162-180. PubMed ID: 27529376
[TBL] [Abstract][Full Text] [Related]
34. Bile Acids Reduce Prion Conversion, Reduce Neuronal Loss, and Prolong Male Survival in Models of Prion Disease.
Cortez LM; Campeau J; Norman G; Kalayil M; Van der Merwe J; McKenzie D; Sim VL
J Virol; 2015 Aug; 89(15):7660-72. PubMed ID: 25972546
[TBL] [Abstract][Full Text] [Related]
35. Preventing prion pathogenicity by targeting the cellular prion protein.
Nicoll AJ; Collinge J
Infect Disord Drug Targets; 2009 Feb; 9(1):48-57. PubMed ID: 19200015
[TBL] [Abstract][Full Text] [Related]
36. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies.
Ciechanover A; Kwon YT
Exp Mol Med; 2015 Mar; 47(3):e147. PubMed ID: 25766616
[TBL] [Abstract][Full Text] [Related]
37. Shedding light on prion disease.
Glatzel M; Linsenmeier L; Dohler F; Krasemann S; Puig B; Altmeppen HC
Prion; 2015; 9(4):244-56. PubMed ID: 26186508
[TBL] [Abstract][Full Text] [Related]
38. Prion protein biology.
Prusiner SB; Scott MR; DeArmond SJ; Cohen FE
Cell; 1998 May; 93(3):337-48. PubMed ID: 9590169
[No Abstract] [Full Text] [Related]
39. Recent advances in the histo-molecular pathology of human prion disease.
Baiardi S; Rossi M; Capellari S; Parchi P
Brain Pathol; 2019 Mar; 29(2):278-300. PubMed ID: 30588685
[TBL] [Abstract][Full Text] [Related]
40. Prion neurotoxicity.
Le NTT; Wu B; Harris DA
Brain Pathol; 2019 Mar; 29(2):263-277. PubMed ID: 30588688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
